Your account has been temporarily locked due to incorrect sign in attempts and will be automatically unlocked in
For immediate assistance, contact Customer Service:
800-638-3030 (within USA), 301-223-2300 (international)
Lippincott Journals Subscribers, use your username or email along with your password to log in.
Registered users can save articles, searches, and manage email alerts.
All registration fields are required.
Flash Player 9.0.0 is required for the Video Gallery.
Get Adobe Flash Player.
Colleague's E-mail is Invalid
Your message has been successfully sent to your colleague.
Current Opinion in Obstetrics and Gynecology. 27(4):284-290, August 2015
The development of a noninvasive accurate marker for endometriosis is a research target and priority of the European Society of Human Reproduction and Embryology. The current markers in use have moderate sensitivity and sensitivity. The inflammatory basis for the disease underpins many biomarkers but also many other concomitant diseases reducing accuracy and increasing false positive results.